Metraipolis › archive › dc_eb2db746ed62
The Ideal Trial: Defining Causal Estimands that Balance Relevance and Feasibility in Target Trial Emulations and Actual Randomized Trials — Europe PMC PMID:41490058
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41490058
- DOI
- 10.1097/ede.0000000000001933
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T12:02:49.168Z
- SHA-256 of the archived text
ca7ea45947cda70f67ed2a19eca1d48f4f3ec9a370f2bd75e680ffb060179d9d- Stable URL of this page
https://metraipolis.com/documento/dc_eb2db746ed62
How to cite
The Ideal Trial: Defining Causal Estimands that Balance Relevance and Feasibility in Target Trial Emulations and Actual Randomized Trials — Europe PMC PMID:41490058 — Europe PMC (en), https://europepmc.org/article/MED/41490058 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb2db746ed62 (Metraipolis archive dc_eb2db746ed62, sha256 ca7ea45947cda70f67ed2a19eca1d48f4f3ec9a370f2bd75e680ffb060179d9d)
BibTeX
@misc{dceb2db746ed62,
title = {The Ideal Trial: Defining Causal Estimands that Balance Relevance and Feasibility in Target Trial Emulations and Actual Randomized Trials — Europe PMC PMID:41490058},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41490058},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb2db746ed62; sha256 ca7ea45947cda70f67ed2a19eca1d48f4f3ec9a370f2bd75e680ffb060179d9d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41490058. Agents can read the archived copy with the MCP tool read_document.